Shares of Imago BioSciences Inc. IMGO, -3.87% soared toward an eight-month high in premarket trading Monday, after the biopharmaceutical company developing treatments for myeloproliferative neoplasms (MPNs) and other bone marrow Read more
Shares of Imago BioSciences Inc. IMGO, -3.87% soared toward an eight-month high in premarket trading Monday, after the biopharmaceutical company developing treatments for myeloproliferative neoplasms (MPNs) and other bone marrow Read more